BARCELONA, July 7 /PRNewswire/ -- The winners of the Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) are announced today at the European Society for Human Reproduction & Embryology Congress. The two winners of this new prize are the University Medical Centre Utrecht, The Netherlands and the Universitair Ziekenhuis (UZ) Brussel, Centre for Reproductive Medicine,Belgium.
The winning research institutions were selected for their outstanding proposals for fundamental research to help gain an increased understanding of the role of human chorionic gonadotrophin (hCG) in assisted reproduction.
"We received a high standard of entries with seven considered in the final judging stage. The judging panel found that the two winning proposals were both innovative and feasible and could help deepen our understanding of an important factor in successful fertility treatment," comments Professor Paul Devroey, Chairman of the FRIGGA judging panel and Professor of Reproductive Medicine at the Centre for Reproductive Medicine, Brussels Free University, Belgium.
The grant is named after Frigga, the goddess of fertility, motherhood, love, family and home from Scandinavian mythology. FRIGGA is a biennial, global grant for fundamental fertility and gynaecology research that was launched by Ferring in January 2008. It received global interest, with 53 entries from 22 countries across the globe. The entries were reviewed anonymously by an independent judging panel composed of experts from around the world. The winning research must be completed and presented by 2010.
"We at Ferring are strongly committed to this area of medicine which we
believe benefits not just those who wish to become parents, but society as
a whole. The Ferring Research Infertility and Gynaecology Grant - The
FRIGGA Award - underlines our continuing commitment to take the lead in
ART," says Dr. Pascal Danglas, Executive Vice President, Clinical R&D and
Product Development, Fe
|SOURCE Ferring Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved